Options
Transforming growth factor-beta receptor type 1 (TGFBR1) is not associated with non-syndromic cleft lip with or without cleft palate in patients of Central European descent
ISSN
0165-5876
Date Issued
2009
Author(s)
Reutter, Heiko
Birnbaum, Stefanie
Mende, Meinhard
de Assis, Nilma Almeida
Hoffmann, Per
Lacava, Amalia Diaz
Herms, Stefan
Braumann, Bert
Scheer, Martin
Lauster, Carola
Schmidt, Guel
Schiefke, Franziska
Dunsche, Anton
Martini, Markus
Knapp, Michael
Noethen, Markus M.
Mangold, Elisabeth
DOI
10.1016/j.ijporl.2009.06.004
Abstract
Objective: Transforming growth factor-beta (TGF-beta) type 1 receptor (also known as activin receptor-like kinase 5, ALK5) is expressed in palatal tissue during embryogenesis. Experimental studies in transgenic mice with a genetic deletion of Alk5 showed that TGF-beta type 1 receptor is required for upper lip and midline fusion of the hard and soft palate. In humans, association of TGF-beta type 1 receptor gene (TGFBR1) and the development of non-syndromic cleft lip with or without cleft palate (NSCL/P) had been observed in a multiethnic sample of Chinese, Philippine, Indian and Turkish families. In order to re-evaluate the relevance of these findings, we carried out a family-based association study among 218 NSCL/P families of Central European descent. Methods: Genomic DNA was obtained from peripheral blood of 218 complete parent-offspring triads with NSCL/P. The sample comprised 14 patients with cleft lip only (CLO) and 204 patients with cleft lip and palate (CLP). Genotyping and transmission disequilibrium test (TDT) were performed on all 218 triads with a total of 17 tagging single-nucleotide polymorphisms (SNPs). We also performed testing for extended haplotypes and a log-linear model by Weinberg was used to screen parent-of-origin effects. Furthermore the use of estimates for the relative risks (RR) of Weinberg's model was obtained. Results: TDT analysis revealed no significant transmission distortion, neither at the level of individual markers nor at the level of haplotypes. Similarly negative results were obtained when we restricted our analysis to the subgroup of patients with CLP (n = 204). Relative risk calculations (RR) of the children's and mothers' genotypes obtained negative results, after correction of p-values for multiple testing. Likewise application of Weinberg's log-linear model did not find any evidence for parent-of-origin effects in our sample. Conclusion: Despite the ample evidence supporting the role of TGF-beta type 1 receptor as a critically important and widespread morphogenetic regulator of craniofacial development in murine models, our results do not support TGFBR I as major risk factor for NSCL/P in patients of Central European descent. (C) 2009 Elsevier Ireland Ltd. All rights reserved.